How Analysts Are Rating Bitcoin Miners' Pivot to AI and Chip Manufacturing
"I expect BTC price appreciation to outpace growth in difficulty," one analyst told Decrypt, which should help improve mining economics in 2025.
Beyond Oil Secures Global Supplier Approval from Restaurant Brands International, Opening Access to Over 30,000 Burger King, Popeyes, Tim Horton's, and Firehouse Sub Locations Worldwide
Global Brand Approval from one of the World's Largest Quick-Service Companies Marks a Major Milestone in Beyond Oil's Global Expansion, Unlocking Unprecedented Growth Opportunities Across the Quick-Service Restaurant Industry Global Brand Approval from one of the World's Largest Quick-Service ...
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
NEW YORK, March 07, 2025 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) ( Euronext Growth: ALCLS- NASDAQ: CLLS ) , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial ...
RAPT Therapeutics to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., March 07, 2025 ( GLOBE NEWSWIRE ) -- RAPT Therapeutics, Inc. ( Nasdaq: RAPT ) , a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological ...
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
SAN FRANCISCO, March 07, 2025 ( GLOBE NEWSWIRE ) -- UNITY Biotechnology, Inc. ( "UNITY" ) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2024.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 ( c ) ( 4 )
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 07, 2025 ( GLOBE NEWSWIRE ) -- ORIC Pharmaceuticals, Inc. ( Nasdaq:ORIC ) , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on March 3, 2025 ( the "Grant ...
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - Cellectis ( NASDAQ:CLLS )
NEW YORK, March 07, 2025 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) CLLS, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the fourth quarter and full ...
Beyond Oil Secures Global Supplier Approval from Restaurant Brands International, Opening Access to Over 30,000 Burger King, Popeyes, Tim Horton's, and Firehouse Sub Locations Worldwide - Beyond Oil ( OTC:BEOLF )
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, March 07, 2025 ( GLOBE NEWSWIRE ) -- Beyond Oil Ltd.
RAPT Therapeutics to Participate in Upcoming Investor Conferences - RAPT Therapeutics ( NASDAQ:RAPT )
SOUTH SAN FRANCISCO, Calif., March 07, 2025 ( GLOBE NEWSWIRE ) -- RAPT Therapeutics, Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Walgreens Boots Alliance ( Nasdaq - WBA ) , Global Blue Group Holding AG ( Nasdaq - GB ) , Playa Hotels & Resorts N.V. ( Nasdaq - PLYA ) , Triumph Group, Inc. ( NYSE - TGI )
BALA CYNWYD, Pa., March 07, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.
